Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang Shang

Showing results (21-30 of 235) with videos related to

Pageof 24
Sort By:
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|June 8, 2007
[Effects of silicon on photosynthesis and antioxidative enzymes of maize under drought stress]Qing-Fang Li, Cheng-Cang Ma, Qi-Liang Shang
Pharmaceutical Research|June 20, 2018
Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2KGuangqing Xiao, Christopher Rowbottom, Carri Boiselle, et al.
Oncology Reports|October 18, 2017
The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastomaQing Ma, Yanmei Liu, Liang Shang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2011
A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitorsPing Li, Chuang Lu, Suresh K Balani, et al.
Minerva Medica|December 6, 2024
Application of percutaneous intervertebral foraminoscopic discectomy in lumbar disc herniationZhi Ruan, Qinzheng Fang, Xiao Zhang, et al.
Current Drug Metabolism|December 8, 2004
CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and developmentGang Luo, Thomas Guenthner, Liang-Shang Gan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Metabolism of (S)-5,6-difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a non-nucleoside reverse transcriptase inhibitor, in human liver microsomes. Metabolic activation and enzyme kineticsHao Chen, Weiqi Chen, Liang-Shang Gan, et al.
Experimental Hematology & Oncology|August 3, 2023
The role of organoids in cancer researchZhen Fang, Peijuan Li, Fengying Du, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|April 6, 2007
Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infectionLiaobin Chen, Hui Wang, Jun Wang, et al.
World Journal of Gastroenterology|August 1, 2015
Newly designed "pieced" stent in a rabbit model of benign esophageal strictureJin Liu, Liang Shang, Ji-Yong Liu, et al.
Pageof 24

Showing results (21-30 of 235) with videos related to

Sort By:
Pageof 24
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|June 8, 2007
[Effects of silicon on photosynthesis and antioxidative enzymes of maize under drought stress]Qing-Fang Li, Cheng-Cang Ma, Qi-Liang Shang
Pharmaceutical Research|June 20, 2018
Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2KGuangqing Xiao, Christopher Rowbottom, Carri Boiselle, et al.
Oncology Reports|October 18, 2017
The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastomaQing Ma, Yanmei Liu, Liang Shang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2011
A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitorsPing Li, Chuang Lu, Suresh K Balani, et al.
Minerva Medica|December 6, 2024
Application of percutaneous intervertebral foraminoscopic discectomy in lumbar disc herniationZhi Ruan, Qinzheng Fang, Xiao Zhang, et al.
Current Drug Metabolism|December 8, 2004
CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and developmentGang Luo, Thomas Guenthner, Liang-Shang Gan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Metabolism of (S)-5,6-difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a non-nucleoside reverse transcriptase inhibitor, in human liver microsomes. Metabolic activation and enzyme kineticsHao Chen, Weiqi Chen, Liang-Shang Gan, et al.
Experimental Hematology & Oncology|August 3, 2023
The role of organoids in cancer researchZhen Fang, Peijuan Li, Fengying Du, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|April 6, 2007
Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infectionLiaobin Chen, Hui Wang, Jun Wang, et al.
World Journal of Gastroenterology|August 1, 2015
Newly designed "pieced" stent in a rabbit model of benign esophageal strictureJin Liu, Liang Shang, Ji-Yong Liu, et al.
Pageof 24